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Abstract
SIRT6 is a member of sirtuin family of deacetylases involved in diverse processes including 
genome stability, metabolic homeostasis and anti-inflammation. However, its function in the 
adipose tissue is not well understood. To examine the metabolic function of Sirt6 in the adipose 
tissue, we generated two mouse models that are deficient in Sirt6 using the Cre-lox approach. Two 
commonly used Cre lines that are driven by either the mouse Fabp4 or Adipoq gene promoter 
were chosen for this study. The Sirt6-knockout mice generated by the Fabp4-Cre line 
(Sirt6f/f:Fabp4-Cre) had a significant increase in both body weight and fat mass and exhibited 
glucose intolerance and insulin resistance as compared with the control wild-type mice. At the 
molecular levels, the Sirt6f/f:Fabp4-Cre-knockout mice had increased expression of inflammatory 
genes including F4/80, TNFα, IL-6, and MCP-1 in both white and brown adipose tissues. 
Moreover, the knockout mice showed decreased expression of the adiponectin gene in the white 
adipose tissue and UCP1 in the brown adipose tissue, respectively. In contrast, the Sirt6 knockout 
mice generated by the Adipoq-Cre line (Sirt6f/f:Adipoq-Cre) only had modest insulin resistance. 
In conclusion, our data suggest that the function of SIRT6 in the Fabp4-Cre-expressing cells in 
addition to mature adipocytes plays a critical role in body weight maintenance and metabolic 
homeostasis.
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Introduction
Obesity has become a global epidemic, contributing to increased risk for type 2 diabetes, 
metabolic syndrome, cardiovascular disease and cancer (Bastien, et al. 2014). In obesity, 
excess expansion of adipose tissue is accompanied by low-grade, chronic inflammation 
characterized by an infiltration of inflammatory cells and an increase in production of 
proinflammatory cytokines (Tseng, et al. 2010). Adipose tissue is the main “storage site” of 
excess energy and plays as a key regulator of energy metabolism by secreting a diverse 
range of adipokines, such as leptin and adiponectin (Galic, et al. 2010). Therefore, adipose 
tissue is considered as highly important for systemic metabolic homeostasis.
The sirtuin deacetylase/deacylase family has seven members in mammals (Sirt1-7) (Dong 
2012). SIRT6 is a chromatin-associated deacetylase that specifically deacetylates histone H3 
at lysine 9 (H3K9), lysine 18 (H3K18) and lysine 56 (H3K56) residues (Michishita, et al. 
2008; Michishita, et al. 2009; Tasselli, et al. 2016; Yang, et al. 2009). SIRT6 modulates 
multiple critical cellular processes, such as DNA damage repair, tumor suppression, 
inflammation and metabolism (Kugel and Mostoslavsky 2014). In recent years, SIRT6 has 
been implicated in a variety of metabolic processes including glycolysis (Zhong, et al. 
2010), gluconeogenesis (Dominy, et al. 2012; Xiong, et al. 2013), hepatic lipid (Kim, et al. 
2010) and cholesterol metabolism (Elhanati, et al. 2013; Tao, et al. 2013a, b), 
neuroendocrine regulation (Schwer, et al. 2010), circadian regulation of metabolism (Masri, 
et al. 2014), as well as pancreatic β-cell function (Xiong, et al. 2016a; Xiong, et al. 2016b). 
However, the role of SIRT6 in adipose tissue is not well understood.
Conditional gene knockout with the use of cell-type specific Cre lines is a powerful 
technique to ablate a specific gene in a target cell type, such as the adipocyte (Wang 2009). 
As a matter of fact, analysis of adipose function in vivo has been benefited from the 
development of several Cre mouse lines that are driven by different gene promoters (Lee, et 
al. 2013). For example, Fabp4-Cre mouse line developed by He et al. (He, et al. 2003) has 
been widely used for the intended adipose gene function studies; however, the Cre activity 
has been also detected in other cell types and tissues, such as macrophages, endothelial, 
intestine, muscle, pancreatic islets, and even central nervous system (Heffner, et al. 2012; 
Lee et al. 2013; Martens, et al. 2010). Another adipocyte-specific Cre line has been 
generated using the mouse adiponectin (Adipoq) gene promoter/enhancer (Eguchi, et al. 
2011). The recombination from Adipoq-Cre mice has been shown very specific for mature 
adipocytes. (Eguchi et al. 2011). In order to assess the SIRT6 function in adipose tissue, we 
crossed Sirt6-floxed mice with either Fabp4-Cre or Adipoq-Cre to generate two different 
mouse models, Sirt6f/f:Fabp4-Cre (Sirt6-FKO) and Sirt6f/f:Adipoq-Cre (Sirt6-AKO), 
respectively.
Materials and Methods
Animal Studies
Sirt6 floxed mice (NIH black Swiss:129/Sv:FVB), Fabp4-Cre and Adipoq-Cre mice 
(C57BL/6J) were purchased from the Jackson Laboratory (Bar Harbor, ME). Sirt6-FKO and 
Sirt6-AKO mice were generated by crossing floxed mice with Fabp4-Cre or Adipoq-Cre 
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mice, respectively. Genotyping was carried out as previously described (Xiong et al. 2016b). 
Blood glucose levels were measured using a glucose meter (Contour from Bayer). High fat 
diet (60% calories from fat) was purchased from Harlan Laboratories (Madison, WI). 
Glucose tolerance test (GTT) and insulin tolerance tests (ITT) were performed in mice 
fasted for 16h or 4h before injection of glucose (i.p. 2g/kg for chow diet mice and 1.5g/kg 
for HFD mice) or insulin (i.p. 0.5U/kg for chow diet mice and 0.75U/kg for HFD mice), 
respectively. For insulin stimulated AKT phosphorylation analysis in WAT, mice were 
starved overnight and injected intravenously with recombinant human insulin (1U/kg, Eli 
Lilly, Indianapolis, IN). WAT was rapidly excised after 3 min of stimulation and 
homogenized for preparation of tissue lysates. All animal procedures were performed in 
accordance with the Guide for Care and Use of Laboratory Animals of the National 
Institutes of Health and were approved by the Institutional Animal Use and Care Committee 
of Indiana University School of Medicine.
Real-time RT PCR
Total RNAs were isolated from tissues using Trizol reagent (Invitrogen) by following the 
manufacturer’s instructions and converted into cDNA using a cDNA synthesis kit (Applied 
Biosystems). Real-time PCR analysis was performed using SYBR Green Master Mix 
(Promega) in Eppendorf Realplex PCR system.
Western blot analysis
Protein extracts from tissues were made in tissue lysis buffer (50 mM Hepes, pH 7.5, 150 
mM NaCl, 10% glycerol, 1% Triton X-100, 1 mM EDTA, 10 mM sodium pyrophosphate, 
100 mM sodium fluoride, and freshly added 1 mM PMSF and an additional protease 
cocktail tablet from Roche at one tablet/10ml final buffer volume). Protein extracts were 
resolved on an SDS-PAGE gel and transferred to nitrocellulose membrane (Santa Cruz 
Biotechnology). The membrane was incubated with the following antibodies: SIRT6 
(Sigma-Aldrich), Actinin (Santa Cruz Biotechnology), AKT, p-AKT(S473), and AdipoQ 
(Cell Signaling Technology). Detection of proteins was carried out by incubations with the 
HRP-conjugated secondary antibodies, followed by the ECL detection reagents (Thermo 
Fisher Scientific).
Histological analysis
Mouse adipose tissues were dissected and immediately fixed in 4% paraformaldehyde. 
Tissues were then routinely processed for paraffin embedding, and 5μm sections were cut 
and mounted on glass slides. Sections were stained with hematoxylin-eosin (H&E) 
according to the standard protocol.
Statistical Analysis
Results are expressed as means ± standard error of the mean (SEM). Group comparisons 
were performed using analysis of variance (ANOVA) and Student’s t-test. A probability 
value of p<0.05 was considered statistically significant.
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Results
Generation of Fabp4-Cre-mediated Sirt6 conditional knockout mice
As we previously reported, Sirt6 is expressed in white adipose tissue (WAT) with an 
abundance similar to that in the liver of mouse (Xiong et al. 2016b). SIRT6 has been shown 
to play important roles in a number of organs/tissues, including liver, heart and islets; 
however, the function of SIRT6 in the adipose tissue is not well understood (Kugel and 
Mostoslavsky 2014). To examine whether SIRT6 protein is affected by diets, we analyzed 
SIRT6 protein in WAT of mice fed with 60% HFD for 5 months, which is commonly used to 
induce diet-induced obesity and diabetes. As shown in Figure 1A and 1B, SIRT6 protein was 
decreased in epididymal fat pads of HFD-fed C57BL/6J mice compared with regular chow-
fed controls. We next sought to determine the effect of Sirt6 deletion in adipose tissue in 
vivo. In order to delete the Sirt6 gene in both pre-adipocytes and mature adipocytes, we 
crossed Sirt6 floxed mice with a widely used Fabp4-Cre line (He et al. 2003) to generate 
Sirt6fl/fl:Fabp4-Cre mice (Sirt6-FKO). As expected, Sirt6 was efficiently deleted in both 
epididymal WAT and interscapular BAT (Figure 2A and 2B).
Increased fat mass and body weight gains in Sirt6-FKO mice
On normal chow, the body weight of Sirt6-FKO mice was increased by ~22% in males and 
~19% in females at 3-month of age (Figure 2C). As expected, both epididymal white fat and 
interscapular brown fat depots were larger in Sirt6-FKO mice and the size of adipocytes was 
bigger in FKO mice than that in control wildtype mice (Figure 2D and 2E). To characterize 
the quality of brown adipose tissue, we analyzed expression of thermogenic genes, such as 
Ucp1, PGC1α and PPARγ, in the intersacpular BAT, and the data showed that all three 
genes were significantly downregulated in the FKO mice (Figure 2F). In addition, blood 
triglyceride and total cholesterol levels were also significantly elevated in Sirt6-FKO mice 
(Figure 2F).
Impaired glucose tolerance and decreased insulin sensitivity in Sirt6-FKO mice
Obesity often leads to glucose intolerance and insulin resistance in human and mice (Tseng 
et al. 2010). To investigate the metabolic effects of Fabp4-Cre mediated deletion of Sirt6 in 
mice, we performed glucose tolerance tests (GTT) to assess glucose homeostasis in the 
Sirt6-FKO mice. As shown in Figure 3A, Sirt6-FKO mice exhibited significant glucose 
intolerance. Insulin sensitivity, as measured by insulin tolerance test, was also significantly 
decreased in Sirt6-FKO mice (Figure 3B). To further examine insulin resistance, we 
measured levels of AKT phosphorylation in WAT without or with insulin stimulation. 
Consistent with the impaired insulin sensitivity phenotype, phosphorylation of AKT was 
significantly decreased in WAT of Sirt6-FKO mice after insulin stimulation although the 
basal levels of phosphorylated AKT in WAT were a little higher in Sirt6-FKO mice (Figure 
3C–3F). As hypertrophic adipocytes secrete more leptin and less adiponectin, the leptin/
adiponectin ratio (LAR) has been proposed as a potentially useful measure of insulin 
resistance (Finucane, et al. 2009). We then further examined the expression levels of leptin 
and adiponectin in WAT of Sirt6-FKO mice. Our data showed that leptin mRNA levels were 
markedly elevated while adiponectin mRNA levels were significantly decreased in the WAT 
of Sirt6-FKO mice (Figure 3G). Leptin concentrations are generally proportional to body fat 
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mass, however, adiponectin concentrations are not. We analyzed adiponectin protein levels 
in WAT of control and Sirt6-FKO mice and found that the FKO mice had lower adiponectin 
compared to the control mice (Figure 3H). Since obesity is associated with a state of 
chronic, low-grade inflammation, we also examined the inflammation status of adipose 
tissues in Sirt6-FKO and control mice. The mRNA levels of major inflammatory markers 
were analyzed in adipose tissues of chow fed control and Sirt6-FKO mice. As shown in 
Figure 4A and 4B, mRNA levels of F4/80 (Adgre1), TNFα, IL-6 and MCP-1 (Ccl2) in both 
WAT and BAT were significantly elevated, suggesting an increased macrophage infiltration 
in the adipose tissues of Sirt6-FKO mice.
Deletion of the Sirt6 gene in mature adipocytes using the Adipoq-Cre mouse line
Fabp4-Cre mice have been reported to exhibit quite broad expression of Cre recombinase in 
both adipose and non-adipose tissues such as brain, muscle, macrophages, and intestine 
(Heffner et al. 2012; Lee et al. 2013; Martens et al. 2010). To further examine whether the 
obesity and insulin resistance phenotype in the Sirt6-FKO mice was due to loss of SIRT6 in 
adipocytes or not, we deleted the Sirt6 gene in mature adipocytes using an Adipoq-Cre 
mouse line (Eguchi et al. 2011). The generated Sirt6fl/fl:Adipoq-cre mice was named as 
Sirt6-AKO. As expected, the AKO mice displayed significantly reduced expression of Sirt6 
in WAT and BAT (Figure 5A and 5B). Interestingly, there was no difference in body weight 
between Sirt6-AKO and control mice at either 3 months or 6 months of age on a chow diet 
(Figure 5C).
Sirt6-AKO mice do not exhibit any significant metabolic phenotype even under HFD 
feeding
Compared to their littermate controls, Sirt6-AKO mice on chow diet exhibited normal body 
weight even at 6 months of age. To assess whether the Sirt6-AKO mice are sensitive to diet-
induced obesity, control wildtype and Sirt6-AKO mice were fed with HFD (60% of calorie 
from fat) for up to 3 months. Surprisingly, HFD fed Sirt6-AKO mice had similar body 
weight and glucose tolerance compared to the control mice although the AKO mice showed 
moderate insulin resistance (Figure 6A–6C). Additionally, expression of common 
inflammatory genes, such as TNFα and IL-6, in WAT did not show any significant 
difference between the control and Sirt6-AKO mice (Figure 6D).
Discussion
The increasing prevalence of obesity has been paralleled by an epidemic level of type 2 
diabetes in the world, and these growing health problems underscore the need to elucidate 
the molecular basis for the obesity pathogenesis and to develop novel treatments for the 
obesity related metabolic disorders (Bastien et al. 2014). Adipose tissue is not only a 
primary depot for lipid storage but also an endocrine organ secreting adipokines for the 
control of energy homeostasis (Galic et al. 2010). In recent years, much effort has been 
made to understand the adipocyte-specific functions of genes of interest. To do so, 
adipocyte-expressing Cre transgenic mice can be used. Among those Cre strains, the Fabp4-
Cre transgenic mouse created by the Ronald Evans group has been widely used in the field 
of adipocyte biology (He et al. 2003). Although FABP4 was originally identified as an 
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adipocyte-specific protein, later studies have shown that FABP4 is also expressed in other 
cell types, including macrophages, the lymphatic system, and embryo (Lee et al. 2013). 
Thus, the Fabp4-Cre is believed to express in multiple cell types other than adipocytes. For 
instance, strong Cre activity has been also noticed in the central nervous system (Martens et 
al. 2010). Recently, another adipocyte-specific Cre line – Adipoq-Cre – has been developed 
with the Cre coding sequence driven by the mouse adiponectin gene promoter/enhancer 
(Eguchi et al. 2011). The recombination by the Adipoq-Cre is highly specific for mature 
adipocytes and absolutely no Cre activity has been observed in other tissues (Lee et al. 
2013). Moreover, the Fabp4-Cre is expressed early on in adipocyte progenitor cells whereas 
the Adipoq-Cre is expressed only after adipocyte differentiation (Lee et al. 2013).
To understand the Sirt6 function in adipocytes, we have generated two mouse models with 
the Sirt6 gene deletion mediated by Fabp4-Cre (Sirt6-FKO) or Adipoq-Cre (Sirt6-AKO), 
respectively. Interestingly, Sirt6-FKO mice exhibit an obesity phenotype, manifested as 
overweight, insulin resistance, glucose intolerance, adipose inflammation. By contrast, no 
significant metabolic phenotype has been observed in Sirt6-AKO mice even challenged with 
HFD. As we obtained a similar Sirt6 knockout efficiency in both mouse models, the 
dramatic differences in the phenotype might be attributable to cell types other than 
adipocytes, for example, immune cells and neurons. Distinct phenotypes for some other 
gene knockouts using Fabp4-Cre and Adipoq-Cre mouse lines have been also reported (Lee, 
et al. 2016; Mullican, et al. 2013; Qiang, et al. 2016). Neural Sirt6 deletion promotes adult-
onset obesity in mice likely through reduced growth hormone (GH) and hypothalamic 
neuropeptide levels (Schwer et al. 2010). It is noteworthy that Cre activity has been reported 
in neurons throughout the central nervous system in the Fabp4-Cre mice (Martens et al. 
2010). Although the obese phenotype is not quite similar between neural Sirt6 deleted mice 
and Sirt6-FKO mice, Fabp4-Cre mediated neural deletion of Sirt6 may contribute, at least in 
part, to the metabolic dysregulation in the Sirt6-FKO mice.
It should be noted that during the revision process of our manuscript, Kuang and coworkers 
reported a fat-specific Sirt6-knockout study by using the same Adipoq-Cre line as ours 
(Kuang et al. 2017). They have shown that Sirt6 deletion in adipocytes exhibits normal 
glucose levels and body weight under chow diet, which is similar to the phenotype we have 
observed in the AKO mice. Interestingly, they have observed that fat-specific deletion of 
Sirt6 sensitizes mice to HFD-induced obesity and insulin resistance by inhibiting lipolysis 
(Kuang et al. 2017). Intriguingly, we have also treated our AKO mice with 60% HFD for 3 
months, but we have not noticed any significant metabolic phenotypes (blood glucose levels, 
body weight, glucose tolerance, insulin resistance, and so forth). The discrepancy of the 
AKO mouse phenotype might be attributed to differences in animal genetic background, 
diet, facility environment, and others.
In conclusion, our data suggest that Sirt6 plays a critical role in the Fabp4+ cells for the 
regulation of adiposity, energy homeostasis, inflammation, insulin sensitivity, and glucose 
metabolism. Therefore, Sirt6 can be a useful therapeutic target for the treatment of obesity 
and diabetes.
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Figure 1. Sirt6 is decreased in white adipose tissues (WAT) of high fat diet (HFD) fed mice
A and B: Western blot (A) and densitometric analysis (B) of Sirt6 in epididymal fat pads of 
male mice fed with 60% HFD for 5 months (n=6 per group). Data are presented as mean ± 
SEM. *, p<0.05.
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Figure 2. Fabp4-Cre mediated Sirt6 deletion in mice leads to obesity
A and B: Western blot (A) and real-time PCR (B) analysis of Sirt6 protein and mRNA in 
WAT and BAT of 3-month-old control and Sirt6:Fabp4-Cre (FKO) mice (n=3 per genotype). 
C and D: Body weight (C) and epididymal fat pad weight (D) of 3-month-old male control 
and FKO mice (n=6–8 per genotype). E: H&E staining of WAT and BAT from 6-month-old 
control and FKO mice. F: Relative mRNA levels of thermogenic genes in BAT of 3-month-
old control and FKO mice (n=3 per genotype). G: Plasma triglyceride and total cholesterol 
levels of 3-month-old male control and FKO mice (n=6–8 per genotype). Data are presented 
as mean ± SEM. *, p<0.05.
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Figure 3. Sirt6-FKO mice exhibit glucose intolerance and insulin resistance
A and B: Glucose tolerance test (GTT, 2g/kg) (A) and insulin tolerance test (ITT, 0.5U/kg) 
(B) in control and FKO mice at 3–4 months of age (n=7–9 per genotype). C and D: Western 
blot for the phosphorylated and total AKT proteins in WAT (C) and quantification by 
densitometry of phosphorylated AKT (p-AKT473) normalized to total AKT (D) for control 
and FKO mice at 3 months of age (n=5 per genotype). E and F: Mice were injected with 
0.5U/kg insulin for 3 minutes. Western blot (E) and quantification by densitometry of 
phosphorylated AKT (p-AKT473) normalized to total AKT (F) in WAT of control and FKO 
mice at 3 months of age (n=5 per genotype). G: Relative mRNA levels of leptin and 
adiponectin in WAT samples of 2-month-old male control and FKO mice (n=4 per 
genotype). H: Western blot analysis of adiponectin (Adipoq) protein level in 3-month-old 
control and FKO mice (n=3 per genotype). Data are presented as mean ± SEM. *, p<0.05.
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Figure 4. Sirt6-FKO mice have increased adipose tissue inflammation
A and B: Relative mRNA levels of inflammation related genes in WAT samples (A) and 
BAT samples (B) of 6-month-old male control and FKO mice (n=4–5 per genotype). Data 
are presented as mean ± SEM. *, p<0.05.
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Figure 5. Deletion of Sirt6 in mature adipocytes using Adipoq-Cre
A and B: Western blot (A) and real-time PCR (B) analysis of Sirt6 protein and mRNA in 
WAT and BAT of 2-month-old control and Sirt6:Adipoq-Cre (AKO) mice (n=3 per 
genotype). C: Body weight of control and AKO male mice with different ages (n=6–8 per 
genotype). Data are presented as mean ± SEM. *, p<0.05.
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Figure 6. Challenge of Sirt6-AKO mice with a high fat diet
Control and AKO male mice were fed with HFD (60% calorie from fat) for 3 months. A: 
Body weight of control and AKO mice before and after the HFD feeding (n=7–8 per 
genotype). B and C: Glucose tolerance test (GTT, 1.5g/kg) (B) and insulin tolerance test 
(ITT, 0.75U/kg) (C) in control and AKO mice fed with HFD for 3 months (n=7–8 per 
genotype). D: Relative mRNA levels of TNFα and IL-6 in WAT of HFD-fed control and 
AKO mice (n=4–5 per genotype). Data are presented as mean ± SEM. *, p<0.05.
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